Brief: Transgene Says Coronavirus Crisis Might Impact Level Of Revenues From Collaborations

Transgene SA

03/04/2020 17:13

April 3 (Reuters) - Transgene SA  TRNG.PA :
    * IMPACT OF COVID-19 AND CONTAINMENT MEASURES COULD CAUSE
DISORGANIZATION OF CLINICAL SITES PARTICIPATING IN CLINICAL
STUDIES, DELAY OR INABILITY TO PRODUCE DRUG CANDIDATES, EVEN
TEMPORARY CLOSURE OF OUR ESTABLISHMENTS
    * ON CORONAVIRUS: COULD CAUSE DYSFUNCTION IN SUPPLY AND
SHIPPING
CHAIN ON WHICH COMPANY DEPENDS, LACK OF VISIBILITY IN SCIENTIFIC
COMMUNITY DUE TO CANCELLATION OF INTERNATIONAL CONFERENCES
    * ON CORONAVIRUS: MATERIALIZATION OF RISKS WOULD HAVE A
DOWNWARD
IMPACT ON COMPANY'S ANTICIPATED LEVEL OF EXPENSES
    * ON CORONAVIRUS: MATERIALIZATION OF THESE RISKS WOULD ALSO
HAVE A
DOWNWARD IMPACT ON COMPANY'S ANTICIPATED LEVEL OF EXPECTED
REVENUES FROM COLLABORATIONS

Source text for Eikon:  ID:nNDL6lGFHx 
Further company coverage:  TRNG.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))